Oragenics is a biotechnology company developing nasal spray treatments for brain injuries and infectious diseases. Their primary focus is a synthetic compound designed to cross the blood-brain barrier to treat swelling and inflammation. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
